Form D · Biotechnology

Obatala Sciences, Inc.

New Orleans, LA · CIK 0001828551

Offering snapshot reported Jan 15, 2021 · SEC filing

Reported sold
$535K
Offering amount: $1.5M
Investors reported
10
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Sep 30, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$268K$535KOct 15, 2020: $200,000.00Oct 15, 2020Jan 15, 2021: $535,000.00Jan 15, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$200,000 → $535,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 15, 2021Amendment$535,000$335,000vs Oct 15, 202010SEC filing
Oct 15, 2020Initial$200,000No comparison10SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-378042
Convertible Notes

Source: Form D, filed Jan 15, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Trivia Frazier Director, Executive
Jeffrey Gimble Director, Executive
Xiying Wu Gimble Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2000 Lakeshore Drive, #4020
New Orleans, LA, 70148